Da Diprosone a Eylea da Fluzelastix a Testex passando per Truqap sono 20 i nuovi farmaci disponibili nelle farmacie. La lista
Nuove specialità medicinali
DIPROSONE soluz cutanea 30 ml 0,05% betametasone dipropionato
ORGANON AIC:023087101 13,20€ Cnn/RR in commercio dal:20/01/2025
EYLEA 1 siringa preriempita 0,184 ml 114,3 mg/ml aflibercept
BAYER AIC:042510040 1.102,23€ Cnn/OSP in commercio dal:24/01/2025
FLUZELASTIX 1 flacone spray nasale 23 g 137 mcg + 50 mcg/erogazione 120 erogazioni azelastina cloridrato/fluticasone propionato
GENETIC AIC:050384015 32,00€ C/RR in commercio dal:27/01/2025
TESTEX 1 flaconcino IM 4 ml 250 mg/ml testosterone undecanoato
SIT LABORATORIO FARMAC. AIC:051015028 160,00€ C/RNRL in commercio dal:27/01/2025
TRUQAP 64 cpr riv 160 mg capivasertib
ASTRAZENECA AIC:051358012 10.057,84€ Cnn/RNRL in commercio dal:20/01/2025
TRUQAP 64 cpr riv 200 mg capivasertib
ASTRAZENECA AIC:051358024 10.057,84€ Cnn/RNRL in commercio dal:20/01/2025
ZILBRYSQ 7 siringhe preriempite SC 0,416 ml 40 mg/ml zilucoplan sodico
UCB AIC:050982014 4.673,11€ H/RRL in commercio dal:20/01/2025
ZILBRYSQ 7 siringhe preriempite SC 0,574 ml 40 mg/ml zilucoplan sodico
UCB AIC:050982038 6.474,80€ H/RRL in commercio dal:20/01/2025
ZILBRYSQ 7 siringhe preriempite SC 0,810 ml 40 mg/ml zilucoplan sodico
UCB AIC:050982053 9.121,02€ H/RRL in commercio dal:20/01/2025
Nuovi farmaci equivalenti
ATORVASTATINA PENSA PHARMA 30 cpr riv 80 mg atorvastatina calcio triidrato
TOWA PHARMACEUTICAL AIC:050704105 13,00€ A/RR in commercio dal:27/01/2025
CABAZITAXEL TILLOMED 1 flaconcino polv EV 60 mg 1,5 ml + 1 flaconcino 5,67 ml solvente cabazitaxel
TILLOMED AIC:047995016 4.476,20€ H/OSP in commercio dal:20/01/2025
CIFOBAN 8 sacche soluz infus 136 mmol/l 1500 ml con sistema di sicurezza safelock sodio citrato
FRESENIUS MEDICAL CARE AIC:049757026 704,00€ Cnn/OSP in commercio dal:17/01/2025
ERIBULINA ADVANZ PHARMA 1 flaconcino EV 2 ml 0,44 mg/ml eribulina mesilato
ADVANZ PHARMA AIC:050248018 417,05€ H/OSP in commercio dal:01/02/2025
METFORMINA EG STADA ITALIA 30 cpr riv 850 mg metformina cloridrato
EG AIC:049629052 2,23€ A/RR in commercio dal:28/01/2025
SARKAMEX 28 cpr riv 20 mg + 5 mg + 12,5 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466015 8,72€ A/RR in commercio dal:24/01/2025
SARKAMEX 28 cpr riv 40 mg + 10 mg + 12,5 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466039 8,72€ A/RR in commercio dal:24/01/2025
SARKAMEX 28 cpr riv 40 mg + 10 mg + 25 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466054 8,72€ A/RR in commercio dal:24/01/2025
SARKAMEX 28 cpr riv 40 mg + 5 mg + 12,5 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466027 8,72€ A/RR in commercio dal:24/01/2025
SARKAMEX 28 cpr riv 40 mg + 5 mg + 25 mg olmesartan medoxomil/amlodipina besilato/idroclorotiazide
ADAMED AIC:048466041 8,72€ A/RR in commercio dal:24/01/2025
TERIFLUNOMIDE HCS 28 cpr riv 14 mg teriflunomide
HCS BV AIC:050545084 688,87€ A/RR in commercio dal:28/01/2025